Financial Results : Dallah 9M 2024 profit soars 45% to SAR 357.3M; Q3 at SAR 126.2M

Dallah 9M 2024 profit soars 45% to SAR 357.3M; Q3 at SAR 126.2M

10/11/2024 Argaam Exclusive

View other reports

Dallah Healthcare Co. reported a net profit of SAR 357.31 million in the first nine months of 2024, an increase of 45% from SAR 246.5 million a year earlier.



Financials (M)

Item 9m 2023 9m 2024 Change‬
Revenues 2,136.89 2,396.97 12.2 %
Gross Income 782.73 914.08 16.8 %
Operating Income 371.97 451.72 21.4 %
Net Income 246.47 357.30 45.0 %
Average Shares 97.68 97.68 -
EPS (Riyals) 2.52 3.66 45.0 %

The profit rise was driven by a 12.2% increase in revenue to SAR 2.4 billion from SAR 2.1 billion a year earlier, due to the expansion in the operational capacity and the continuing growth in the number of patients in the group’s hospitals.

 

The improvement in the performance of associates led to a profit of SAR 28 million during the period, against losses of SAR 5 million in the same period of the prior year.



Current Quarter Comparison (M)

Compared With The
Item Q3 2023 Q3 2024 Change‬
Revenues 749.83 847.73 13.1 %
Gross Income 280.86 322.99 15.0 %
Operating Income 130.97 161.42 23.3 %
Net Income 98.87 126.16 27.6 %
Average Shares 97.68 97.68 -
EPS (Riyals) 1.01 1.29 27.6 %

The third-quarter net profit rose to SAR 126.2 million, up 28%, from SAR 98.9 million in Q3 2023.

 

The net profit improved 12.8% from SAR 111.8 million in Q2 2024.

 

Shareholders’ equity, after excluding minority interest, rose to SAR 3.41 billion as of Sept. 30, 2024, from SAR 3.18 billion a year earlier.

 

Dallah signed, on Aug. 19, a binding acquisition and subscription agreement with AYYAN Investment Co. to purchase the latter’s stakes in Al-Ahsa Medical Services Co. and Al-Salam Medical Services Co.

 

The agreement included acquiring 97.4% of the capital of Al-Ahsa (which owns Al-Ahsa Hospital in Al-Ahsa) and 100% of the capital of Al-Salam (which owns Al-Salam Hospital in Al-Khobar).

 

On Sept. 19, Dallah and AYYAN announced the issuance of a no-objection from the General Authority for Competition (GAC) to complete the economic concentration process.

 

Attached Document:

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Quarterly Actuals vs Estimates 10/11/2024


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.